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Abstract
We aimed to examine the global prevalences of central obesity according to age, sex, race, place of residence, geographical 
region, national income level, and the definitions of central obesity. MEDLINE and Embase were searched. Studies with 
sample size of ≥ 500 and investigated individuals aged ≥ 15 years were included. Metaprop (a Stata command) was adopted 
to conduct a meta-analysis of prevalence, and the Freeman-Tukey Double Arcsine Transformation was used to stabilize the 
variances. A random-effects model was used to evaluate the prevalence and 95% confidence intervals (CI) of central obesity. 
There were 288 studies involving 13,233,675 individuals in this analysis. The overall prevalence of central obesity was 41.5% 
(95% CI 39.9–43.2%). A higher prevalence was found in older individuals, female subjects, urban residents, Caucasians, and 
populations of higher income level countries. Regarding regional variations, the highest prevalence was found in Sothern 
America (55.1%, 95% CI 45.8–64.3%) and Central American (52.9%, 95% CI 32.7–72.7%). Its prevalence was rapidly ris-
ing from 1985 to 2014. From 1985–1999 to 2010–2014, younger subjects aged 15–40 years showed a more drastic rise in 
prevalence (16.3 to 33.9%) than subjects aged > 40 years (43.6 to 57.9%). Male individuals have a more drastic rise (25.3 to 
41.6%) than females (38.6 to 49.7%). Major increasing in prevalence of the condition in the past three decades, particularly 
in certain subgroups. These findings could act as a useful reference to inform public health strategies to minimize the impact 
of central obesity on population health.
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Introduction
Central obesity is defined by the World Health Organiza-
tion defined central obesity as a waist circumference (WC) 
of greater than 94 cm and 80 cm for males and females, 
respectively. The International Diabetes Federation proposed 
different cut-off points for different ethnic groups (e.g. 94 cm 
for males and 80 cm for females for Europeans, 90 cm for 
males and 80 cm for females for Asians) [1]. The prevalence 
of central obesity is rising globally due to a combination of 
physical inactivity and consumption of unhealthy diet [2]. 
This has contributed significantly to increased financial bur-
den [3] and avoidable utilization of the healthcare system 
[4].
Central obesity could contribute to an increased risk of 
many medical conditions, including cardiovascular diseases 
(CVD)[5], stroke [6], type 2 diabetes mellitus[7], hyperten-
sion [8], various types of cancer (e.g. colorectum, pancreas, 
endometrium, and breast) and all-cause mortality [9]. It is 
also associated with other co-morbidities, such as dyslipi-
demia, hip fracture [10], and depression. Some studies sup-
ported WC as a better predictor for CVD than body mass 
index (BMI). A recent study reported that WC had a higher 
relative integrated discrimination index than BMI in both 
men (6.9% versus 3.2%) and women (9.6% versus 9.2%) 
[11]. Although total cholesterol, HDL-C, hypertension, and 
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diabetes appeared to mediate the risk incurred by central 
obesity, the association between WC and CVD risk remained 
significant after controlling for these factors. This indicated 
that central obesity may play an important role in the pri-
mary prevention of CVD.
Determining the regional and time-trend prevalence of 
central obesity is important as it may inform resource alloca-
tion and policy making to reduce its disease burden through 
health education, screening and early intervention. However, 
the reported prevalence of central obesity in existing litera-
ture may be affected by the research settings (e.g. geographi-
cal region, place of residence, and study time period), the 
characteristics of the population groups studied (e.g. age 
range, gender proportion and race), sampling methods, 
diagnostic criteria, and other factors. A systematic review 
is required to obtain a comprehensive examination of cen-
tral obesity as a global disease burden. As there is no such 
previous study identified, we aim to perform a systematic 
review and meta-analysis of the worldwide and time-trend 
prevalence of central obesity.
Methods
Search strategy and selection criteria
MEDLINE and Embase were searched for population-based, 
epidemiological studies reporting the prevalence of central 
obesity from our previous database of metabolic syndrome. 
A pre-determined search strategy (Supplementary Table 1) 
was used to search literature according to the quality of 
reporting of the MOOSE (Meta-analyses Of Observa-
tional Studies in Epidemiology) guidelines (Supplementary 
Table 2) [12].
A multidisciplinary group conducted the meta-analysis 
led by MCSW with JH, JW, PSFC, and VL as reviewers. 
Consensus was reached by referral to a third reviewer (XC) 
when there was disagreement. All returned citations were 
screened by title and abstract first, followed by full texts if 
relevant. The pre-determined criteria in the initial screen-
ing stage were studies (1) investigating the prevalence of 
central obesity; (2) using observational design; (3) reporting 
original data. Citations remained were eligible for full-text 
screening. Only population-based studies were reviewed, 
and they were defined as those that involved all residents in 
a specific region as the sampling frame based on a sampling 
method that was representative of that region. Additionally, 
the studies should: (1) have a sample size of no less than 500 
participants; (2) have investigated individuals aged no less 
than 15 years; (3) adopt clinical approaches of Adult Treat-
ment Panel (ATP III), International Diabetes Federation 
(IDF), World Health Organization (WHO) or Joint Interim 
Statement (JIS) to assess central obesity; and (4) contain 
sufficient information to calculate the number of individu-
als with central obesity. If there were citations based on the 
same study, the one reporting the most detailed information 
was used.
Data extraction and quality assessment
Basic information collected from the individual studies con-
sists of the name of first author; year of publication; study 
time period (the period in which the study was performed); 
country and region of recruitment (urban vs. rural); age 
range; sex; as well as ethnicity of the study participants. 
Relevant information was extracted to estimate prevalence, 
and the data retrieved included definitions of central obesity; 
sample size and case numbers; and crude/age-specified/sex-
specified prevalence rate. Different criteria of central obesity 
were shown in Supplementary Table 3. The classification 
of regions including income group were clarified in Sup-
plementary Table 4. Two reviewers (PSFC, JW) indepen-
dently evaluated the quality of each included citation using 
the modified Newcastle–Ottawa-Quality Assessment Scale 
(NOS) [13].
Statistical analysis
A systematic, analytical method was used to compute the 
pooled prevalence rate of central obesity from all included 
studies. A Stata command, “metaprop”, was adopted to 
conduct meta-analysis of rates to generate pooled estimates 
with exact binomial and score test-based confidence inter-
vals (CIs) [14]. The method provided appropriate ways of 
combining rates close to the margins by using the Free-
man–Tukey Double Arcsine Transformation to stabilize 
the variances. A random-effects model was used to pool 
the prevalence of central obesity with proportions and 95% 
CIs. Heterogeneity across different studies was calculated 
using Cochran’s Q test and chi square statistics. Subgroup 
analysis by age, sex, race, place of residence, geographi-
cal region, national income level (according to World Bank 
Income Group in 2017), and definition of central obesity 
were conducted to explore the observed heterogeneity. Tem-
poral trends of the prevalence of central obesity in different 
age and sex groups were investigated by subgroup analysis. 
A choropleth map, which used differences in shading to indi-
cate the prevalence rate of central obesity in different coun-
tries, was generated for the overall estimation of prevalence 
rates. Univariate and multivariate meta-regression analysis 
were conducted to identify potential effects of confounders 
or modifiers. Sensitivity analysis was performed by omitting 
one study at a time, generating the pooled estimates and 
comparing with the original estimates to examine the stabil-
ity of the results. A choropleth map was generated for the 
overall estimated prevalence of central obesity in individual 
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countries. The statistical analysis was conducted using Stata 
version 14.0 (College Station, Texas). The graphic composi-
tions were performed by R version 3.3.2 (R Core Team).
Results
In the literature search, 29,095 citations were identified, 
of which 20,160 were from Embase and 8,935 were from 
MEDLINE (Fig.  1). There were 21,591 citations after 
removal of duplicates. We retrieved 409 full-text articles 
assessed for eligibility after 21,182 citations were excluded 
during title or abstract screening as they did not investigate 
the prevalence of central obesity, use an observational 
design, or report original data. We excluded 150 articles as 
they were not population-based; the sample size was smaller 
than 500; there were no sufficient information to calculate 
the crude prevalence; or due to duplicate data source. Some 
publications recruited subjects with more than one ethnic-
ity; or were performed across decades. We considered them 
as articles containing multiple studies, and more than one 
prevalence rates were extracted in this type of publication. 
Finally, there were 288 studies in 259 articles included in the 
present meta-analysis.
The characteristics of all eligible studies were shown in 
Supplementary Tables 5, and the quality of these studies 
Fig. 1  Selection of articles for 
systematic review
150 articles excluded
• 5 not population-based studies
• 1 sample size < 500
• 143 no prevalence or enough information to 
calculate the crude rates
• 1 duplicate
288 studies in 259 articles included in systematic review
409 full-text articles assessed for eligibility
21,182 citations excluded in screening of titles or 
abstracts with pre-determined criteria
• 20,866 not prevalence studies on central obesity
• 238 not observational studies 
• 78 did not report original data
21,591 citations after duplicates removed
29,095 citations identified from literature search
• 20,160 from Embase
• 8,935 from MEDLINE
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as assessed by the NOS was presented in Supplementary 
Table 6. Among 259 citations, 174 citations (67.2%) were 
judged to have high quality in both patient definition and 
data representativeness. Prevalence figures were presented 
for Western Europe (11 studies), Northern Europe (10), East-
ern Europe (10), Southern Europe (21), Eastern Asia (100), 
Western Asia (25), Southern-Central Asia (30), South-East-
ern Asia (8), Northern America (31), Central America (5), 
Southern America (21), and Africa (16). Trained staffs were 
recruited to measure the waist circumference in 273 studies 
(94.8%) while other studies did not mention how the data 
were collected (n = 15, 5.2%).
The results of meta-analysis were presented in Figs. 2, 
3 and 4. The overall prevalence of central obesity in 288 
selected studies involving 13.2 million individuals was 
41.5% (95% CI 39.9%-43.2%;  I2 99.9%). Time trend was 
classified by 4 periods (i.e. 1985–1999, 2000–2004, 
2005–2009 and 2010–2014, Fig.  4). We stratified the 
study period into four groups, taking a balance between 
the number of groups and sample size within each group 
into consideration. An increasing trend of prevalence was 
observed across time periods. The prevalence of each period 
was 31.3% (1985–1999, 95% CI 26.9–35.0.8%;  I2 99.8%), 
38.3% (2000–2004, 95% CI 33.1–43.5%;  I2 99.9%), 46.3% 
(2005–2009, 95% CI 42.4–50.3%;  I2 99.9%) and 48.3% 
(2010–2014, 95% CI 42.4–54.3%;  I2 100.0%), respec-
tively. Regarding age-specific prevalence, the older group 
(age > 40 years) (48.0%, 95% CI 43.7–52.4%;  I2 99.9%) had 
a higher prevalence than the younger group (15–40 years) 
(23.8%, 95% CI 20.5–27.2%;  I2 99.6%). Besides, the 
overall prevalence was higher in female (47.6%, 95% CI 
45.6–49.5%;  I2 99.8%) than male individuals (30.4%, 95% 
CI 28.2–32.6%;  I2 99.9%).
When the time trend was analysed by different sex and 
age groups, an even sharper increase was observed among 
young adults and male subjects than other subgroups 
(Fig. 4). Among adults aged 15–40 years, the prevalence 
increased from 16.3% (95% CI 10.7%-22.7%;  I2 99.6%) 
during 1985–1999 to 33.9% (95% CI 25.0–43.4%;  I2 
99.3%) during 2010–2014. For adults aged > 40 years, it 
increased from 43.6% (95% CI 33.9–53.5%;  I2 99.9%) dur-
ing 1985–1999 to 57.9% (95% CI 40.9–73.9%;  I2 99.9%) 
during 2010–2014. We chose the age of 40 years as a cut-
off due to this value was adopted in more primary stud-
ies. For male individuals, the prevalence increased from 
25.3% (95% CI 21.0–29.9%;  I2 99.7%) during 1985–1999 
Overall
Age
Young 15−40y
Old >40y
Sex
Male
Female
Place
Urban
Rural
Criteria
WHO
ATP
IDF
JIS
Race
Asian
Caucasian
African
No. of studies
288
57
85
198
208
64
30
25
168
98
29
69
131
20
Sample size
13,233,675
176,111
1,126,883
6,435,220
5,302,583
238,967
91,438
546,711
12,800,000
1,082,750
229,554
12,200,000
555,786
30,218
Prevalence(95%CI)
0.415(0.399,0.432)
0.238(0.205,0.272)
0.48(0.437,0.524)
0.304(0.282,0.326)
0.476(0.456,0.495)
0.437(0.395,0.479)
0.342(0.284,0.402)
0.536(0.414,0.657)
0.359(0.336,0.383)
0.483(0.438,0.528)
0.359(0.296,0.425)
0.313(0.287,0.339)
0.466(0.438,0.494)
0.457(0.374,0.540)
Heterogeneity
99.90%
99.60%
99.90%
99.90%
99.80%
99.80%
99.70%
99.90%
100.00%
99.90%
99.90%
100.00%
99.80%
99.50%
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9
Fig. 2  Prevalence of central obesity by age, sex, place, criteria, and race
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to 41.6% (95% CI 31.7–51.7%,  I2 = 100.0%) during 
2010–2014. For female adults, it increased from 38.6% 
(95% CI 33.2–44.0%;  I2 99.8%) during 1985–1999 to 
49.7% (95% CI 43.9–55.5%,  I2 99.9%) during 2010–2014.
Individuals living in urban regions (43.7%, 95% 
CI 39.5–47.9%;  I2 99.8%) had a higher prevalence 
than individuals living in rural regions (34.2%, 95% 
CI 28.4–40.2%;  I2 99.7%) (Fig.  2). Diagnostic crite-
ria using WHO, ATP, IDF and JIS are the most com-
mon used. The prevalence of central obesity based on 
WHO is 53.6% (95% CI 41.4–65.7%;  I2 99.9%), ATP is 
35.9% (95% CI 33.6–38.3%;  I2 100.0%), IDF is 48.3% 
(95% CI 43.8–52.8%;  I2 99.9%) and JIS is 35.9% (95% 
CI 29.6–42.5%;  I2 99.9%). When compared with Cauca-
sian (46.6%, 95% CI 43.8–49.4%;  I2 99.8%) and African 
(45.7%, 95% CI 37.4–54.0%;  I2 99.5%) population, Asian 
people (31.3%, 95% CI 28.7–33.9%;  I2 100.0%) were 
reported to have lower prevalence. Regarding regional 
variations, the highest prevalence was found in Sothern 
America (55.1%, 95% CI 45.8–64.3%;  I2 99.6%) and Cen-
tral American (52.9%, 95% CI 32.7–72.7%;  I2 99.6%) fol-
lowed by Southern Europe (51.9%, 95% CI 46.6–57.3%;  I2 
99.5%) (Fig. 3). The highest prevalence in Asian regions 
was found in Western Asia (48.0%, 95% CI 43.7–52.3%; 
 I2 99.3%). The prevalence in Africa was 49.6% (95% CI 
38.3%-60.8%;  I2 99.7%). The prevalence was higher in 
high-income (41.2%, 95% CI 38.9–43.5%;  I2 99.9%) than 
low-income countries (27.8%, 95% CI 18.1–38.7%;  I2 
99.3%).
A choropleth map for the prevalence of central obesity 
indicates substantial variations across different countries 
(Fig. 5). Regions with the highest prevalence (over 55%) 
include Hungary (67.0%), Peru (64.7%), Kuwait (64.5%), 
Mongolia (64.3%), Qatar (62.0%), Pakistan (61.8%), South 
Africa (58.4.5%), Jordan (58.4%), Poland (57.9%), Suriname 
(57.4%), Greece (56.8%), and Croatia (56.5%). Regions with 
the lowest prevalence (below 30%) include Nigeria (6.2%), 
Bangladesh (15.3%), Vietnam (15.4%), Sri Lanka (16.2%), 
Taiwan (18.7%), Philippines (22.4%), Nepal (22.9%), France 
(25.9%), and Jamaica (29.2%).
We performed a meta-regression analysis to investi-
gate study-level factors that may impact the estimation on 
prevalence of central obesity and contribute to heteroge-
neity across studies (Supplementary Table 7). The results 
showed that the estimation on prevalence of central obesity 
was not substantially altered by region (p = 0.071–0.779), 
criteria (p = 0.099–0.849), measurement method (p = 0.657), 
or study quality (p = 0.330). In the univariate meta-regres-
sion analysis age (p = 0.007), region (p = 0.042), place 
(p < 0.001), period (p < 0.001), and study quality (p = 0.042) 
were associated with the heterogeneity observed. However, 
in the multivariate regression analysis, only age (p = 0.001), 
Region
Europe
Western
Northern
Eastern
Southern
Asia
Eastern
Western
South−Central
South−Eastern
America
Nothern
Central
Southern
Africa
Income of countries
High
Upper middle
Lower middle
Low
No. of studies
52
11
10
10
21
163
100
25
30
8
57
31
5
21
16
124
134
19
5
Sample size
373,089
177,268
29,403
93,056
73,362
12,370,310
12,132,789
81,660
99,289
56,572
240,445
164,048
9,087
29,876
26,274
11,602,797
1,249,540
41,792
19,408
Prevalence(95%CI)
0.472(0.433,0.512)
0.426(0.347,0.507)
0.419(0.352,0.487)
0.478(0.345,0.613)
0.519(0.466,0.573)
0.363(0.344,0.382)
0.336(0.312,0.361)
0.480(0.437,0.523)
0.369(0.321,0.419)
0.320(0.241,0.404)
0.470(0.412,0.528)
0.414(0.364,0.490)
0.529(0.327,0.727)
0.551(0.458,0.643)
0.496(0.383,0.608)
0.412(0.389,0.435)
0.428(0.390,0.466)
0.353(0.266,0.444)
0.278(0.181,0.387)
Heterogeneity
99.80%
99.90%
99.20%
99.90%
99.50%
99.90%
100.00%
99.30%
99.60%
99.70%
99.90%
99.90%
99.60%
99.60%
99.70%
99.90%
99.90%
99.70%
99.30%
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8
Prevalence of central obesity in all selected studies
Fig. 3  Prevalence of central obesity by region and income level
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Time trend
1985−1999
2000−2004
2005−2009
2010−2014
Male
1985−1999
2000−2004
2005−2009
2010−2014
Female
1985−1999
2000−2004
2005−2009
2010−2014
15−40 yr
1985−1999
2000−2004
2005−2009
2010−2014
>40 yr
1985−1999
2000−2004
2005−2009
2010−2014
No. of studies
41
63
71
35
41
54
53
31
43
53
58
31
7
15
19
7
10
23
22
10
Sample size
389,140
826,256
1,205,016
10,600,000
150,217
140,888
191,947
5,885,465
170,892
145,450
242,390
4,644,571
18,396
40,195
67,245
33,433
51,490
86,793
855,327
77,438
Prevalence(95%CI)
0.313(0.269,0.358)
0.383(0.331,0.435)
0.463(0.424,0.503)
0.483(0.424,0.543)
0.253(0.210,0.299)
0.277(0.233,0.324)
0.315(0.274,0.357)
0.416(0.317,0.517)
0.386(0.332,0.440)
0.450(0.389,0.512)
0.533(0.498,0.567)
0.497(0.439,0.555)
0.163(0.107,0.227)
0.233(0.175,0.296)
0.273(0.231,0.317)
0.339(0.250,0.434)
0.436(0.339,0.535)
0.467(0.395,0.539)
0.502(0.407,0.598)
0.579(0.409,0.739)
Heterogeneity
99.80%
99.90%
99.90%
100.00%
99.70%
99.70%
99.70%
100.00%
99.80%
99.80%
99.60%
99.90%
99.60%
98.90%
99.00%
99.30%
99.90%
99.60%
100.00%
99.90%
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8
Fig. 4  Time trend prevalence of central obesity by sex and age
Fig. 5  Global prevalence of central obesity by country
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place (p < 0.001), and period (p < 0.001) remained to be the 
sources of heterogeneity. It was found that the prevalence 
of central obesity was higher in studies on older individu-
als (median age ≥ 55 years vs < 55 years, adjusted risk ratio 
(ARR) 1.23, 95% CI 1.09–1.38), residents in urban regions 
(urban vs rural, ARR 1.70, 95% CI 1.31–2.19), and the more 
recent decade (2005–2014 vs 1980–2004, ARR 1.34, 95% 
CI 1.17–1.53).
The sensitivity analysis shows that the results of the over-
all prevalence estimation were not affected by excluding any 
single study, indicating the stability and robustness of the 
results (Supplementary Table 8).
Discussion
This systematic review provided a comprehensive and up-
to-date analysis on the global prevalence of central obesity 
by different sociodemographic characteristics, its various 
diagnostic criteria, national income of countries where the 
study subjects were living in; as well as its temporal tend by 
age and sex, respectively. We found a rising trend in overall 
prevalence since the 1990s and this trend was more drastic in 
young adults and male individuals. A higher prevalence was 
found in older subjects, females, urban regions, Caucasians, 
and people from higher income countries.
The overall prevalence of central obesity was estimated 
to be 41.5% (95% C.I. 39.9–43.2%), with an obvious 
increase since the 1990s from 31.3% (1985–1999) to 48.3% 
(2010–2014). This increasing trend of prevalence in central 
obesity could be attributed to economic development and 
urbanization which could lead to an unfavourable change 
in dietary habits (consumption of high-calorie foods and 
sweetened beverages) [15], physical inactivity [16], sed-
entary behaviours (smartphone use, computer use, TV or 
video viewing), stress and cortisol secretion [17]. The global 
dietary habits have changed in obvious ways in the last four 
decades. Dietary habits in the population have transformed 
to a greater intake of processed and over-processed meats 
and drinks that are lacking nutrients and excess in calorie 
[18]. The over intake of processed food has also been associ-
ated with lower consumption of some healthy nutrient com-
ponents, including white meat, legumes, coarse grains, fruits 
and other vegetables [19]. The consumption of sodium, fats, 
and sugars did not meet the levels recommended by guide-
line in many regions [20, 21]. Decreases in physical activity 
are continuously popular over the past four decades [22] 
and may have contributed to the increased prevalence in 
central obesity. Industrialization has resulted in some risk 
factors, including air pollution, heavy traffic transportation, 
high-density buildings, limited resources of green space 
and sports facilities, and violence, which may have caused 
some barriers to the access of physical activity [23]. The 
current low levels of physical activity are attributed to the 
less involvement in physical activities and an increasing 
trend of sedentary behaviour in the working and domestic 
environments [24]. The WHO has made an agreement on 
a voluntary global non-communicable diseases programme 
goal for an increase of 10% in physical activity by 2025 [25].
The prevalence of central obesity among individuals 
aged > 40 were around twice as much as that in younger 
adults aged 15–40 (48.0 vs. 23.8%). This is well under-
stood by researchers as the basal metabolic rate is lower 
in old adults than in young adults [26], leading to excess 
fat stored in the body due to an increase in energy intake: 
energy expenditure ratio [27]. Another reason could be older 
individuals may not be as physically active as young adults 
and have lower energy expenditure [49]. Despite the above 
facts, it is remarkable that the prevalence of central obesity 
among young adults increased by twice as much as that in 
older subjects from 1985–1999 to 2010–2014. This could 
be attributed to more individuals, such as children and ado-
lescents, are having central obesity at an earlier stage of 
their life [28, 29]. This trend has been speculated to rise 
continuously in the future given the lifelong exposure and 
with inevitable ageing. Obesity may be associated with 
higher risks of complications, including diabetes, hyperten-
sion, lipid disorders, and cancers in different ages [30–33]. 
A study found age at onset of obesity was negatively asso-
ciated with risk of diabetes [34]. Similarly, another study 
concluded the mortality decreased with onset age of obesity. 
They observed the lowest mortality in subjects with obesity 
onset at > 50 years but the highest mortality in people with 
obesity onset at 18 to 29 years [35]. We have also conducted 
an analysis of the epidemiology of colorectal cancer from 39 
countries, and found that the incidence of colorectal cancer 
continued to increase in younger populations. This may be 
partly explained by the increasing prevalence of central obe-
sity among younger individuals [36]. Therefore, the impli-
cations for medical professionals and supporting agencies 
are to encourage the prevention of central obesity, weight 
loss and more physical activity in the younger population. 
Besides, attention need to be paid on early detecting, closely 
monitoring and positively reversing metabolic syndrome for 
all patients, especially those in younger age. Aging is also 
associated with progressive transitions in fat distribution, 
which refers to the increase in abdominal fat combined with 
a decrease in lower body subcutaneous fat. This age-related 
fat redistribution is associated with an increased risk of mor-
bidity and mortality. However, the impacts of lifestyle risk 
factors on fat redistribution remained unknown [37].
The global prevalence of central obesity was estimated 
to be higher among females when compared with males 
(47.6 vs. 30.4%, respectively). In additional to the biologi-
cal differences where females generally have higher body fat 
proportion than that of males and need more essential fat, 
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cultural factors and social restrictions may also explain this 
gender difference. Women generally have less physical activ-
ity because of a lower education level, sedentary lifestyle 
and a higher level of housework engagement [38, 39]. Also, 
sex hormones and the effect of menopause might explain the 
differences in prevalence between males and females [40, 
41]. Central obesity seems to be associated with low levels 
of testosterone as the hormone promotes fat consumption 
and decrease central obesity [42–45]. The high prevalence 
of central obesity in females implicates the importance to 
implement healthy lifestyle modification strategies for this 
group. Although the prevalence of central obesity was higher 
in females in both periods, the increasing rates of central 
obesity were higher in males (from 25.3 to 41.6%) compared 
with females (from 38.6 to 49.7%). This may be related to 
the difference in the prevalence trend of lifestyle risk factors 
by genders. The prevalence of males (50.0%) smoking was 
three times the prevalence of users among females (16.7%) 
in 2000. By 2015, the prevalence for males (40.3%) was 
more than four times the prevalence for females (9.5%). It 
was estimated that the prevalence for males (35.1%) is five 
times the prevalence for females (6.7%) by 2025 [46]. In 
terms of alcohol consumption, its global adult per-capita 
had increased from 5.9 to 6.5 L in the past three decades 
and is expected to grow to 7.6 L in the next decade [47]. 
The sex ratios (males/ females) for heavy episodic drink-
ing have increased from 2.3 in 2000 to 2.5 in 2016 [48]. As 
for physical activity, It was found by a recent analysis that 
females were less active than males and the prevalence of 
female physical activity has not increased since 2001 [49]. 
Therefore, the prevalence of central obesity among females 
is expected to rise further and contribute to a more substan-
tial disease burden. This represents a target group where 
preventive measures and clinical management should be 
strengthened. Evidence-based approaches are needed to 
enhance its early detection, formulate lifestyle modification 
strategies, and devise evidence-based guidelines in order to 
mitigate its rising trends and ameliorate its associated mor-
bidity and mortality.
The prevalence of central obesity was 44.7% in high-
income and 43.6% in upper-middle income countries, 
compared with 30.1% in lower-middle income and 30.6% 
in low-income countries. Economic development is asso-
ciated with a high risk of obesity [50]. Economic theory 
suggested that obesity may be attributed to scientific and 
technological advances which had altered people’s dietary 
habits, lifestyles and work patterns [51]. This may also be 
applied to central obesity. Previous studies have discussed a 
dose–response association between exposure to work stress 
and the development of central obesity [52], which pos-
sibly induce central obesity through dysregulation of the 
hypothalamic–pituitary–adrenal axis [53]. The high preva-
lence of central obesity in upper-middle-income countries 
and high-income countries highlights the importance for 
physicians and policymakers to implement health promo-
tion strategies for their patients and the general population. 
As the economy grows, the prevalence of central obesity 
in the underdeveloped regions is expected to increase fur-
ther. There is a rising trend in the developing regions, where 
the economic and lifestyle transition imposes more con-
straints on facing the double burden of communicable and 
non-communicable diseases (NCDs) in an underprivileged 
environment, characterized by poor health systems [54]. It 
was reported that NCDs resulted in more than half of all 
mortality in low- and middle-income nations (29 million 
deaths annually).[55]. NCDs are increasing in all over the 
world but most rapidly in the region of sub-Saharan Africa, 
where the estimated rise in NCDs will outpace the decrease 
in communicable diseases [56].
Study limitations
This study was the first comprehensive meta-analysis that 
examined the global prevalence of central obesity taking 
sociodemographic variables, peoples’ races, geographi-
cal regions, and national income into consideration. It has 
a large sample size of over 13 million subjects. However, 
several limitations should be addressed. Firstly, the degree 
of heterogeneity in this study was large (I2 > 98%). The 
included studies had a long-time span (from 1985 to 2014); 
adopted different sampling methods; and possessed a huge 
between-study variation in sample size and age range. Nev-
ertheless, a pervious study indicated that the measurement 
of heterogeneity by I2 can be influenced by large sample 
size and could be large (> 75%),[57], and any amount of 
heterogeneity is acceptable if both accurate data and pre-
defined eligibility criteria were provided [58]. In addition, 
inconsistent criteria used in different studies made direct 
comparison of findings challenging, yet additional sensitiv-
ity analysis had showed the distribution of definitions used 
was mostly balanced between groups. Also, it is difficult to 
compare the prevalence trend across countries and popula-
tions at different times. These weaknesses may have limited 
the generalizability of the results to a particular region or 
population.
Conclusions
In summary, this meta-analysis estimated the global prev-
alence of central obesity in the past few decades using 
more than 280 population-based studies worldwide. The 
estimated global prevalence is 41.5% among individuals 
aged 15 or above. Higher prevalence was found in indi-
viduals aged > 40 years, females, people living in urban 
regions, Caucasian and African population, and residents 
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in high-income countries. We also identified an increase 
in the overall prevalence, and a more drastic increase in 
younger subjects and male subjects according to temporal 
trend. Therefore, it is of vital importance for the government 
and health organizations to devise and implement preventive 
measures and early interventions to tackle its rising threat. 
Besides the general population, measures at individual and 
public health levels targeted at the high-risk groups (e.g. 
Caucasian or African older adults and females) may rep-
resent cost-effective means to control its growing burden. 
However, the measurements should be tailored for individual 
country or population as the epidemiology of central obesity 
could vary between countries or populations.
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